GSE182954
RNA sequencing analysis of wild-type and BML-210 treated breast cancer EO771
We investigated the molecular mechanism by which BML-210 enhanced the response of breast tumor cells to cytotoxic CD8+ T cells. For this purpose, we performed RNA sequencing and analyzed the genome-wide gene expression profiles to systematically identify transcriptom reprogramming in the BML-210-treated cells. Overall design: Comparison of total RNA expression profile of wild-type and BML-210 treated breast cancer EO771